MRI Contrast Media is contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI) The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
Market Analysis and Insights: Global and United States MRI Contrast Media Market
This report focuses on global and United States MRI Contrast Media market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global MRI Contrast Media market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Injection Type accounting for % of the MRI Contrast Media global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the MRI Contrast Media market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global MRI Contrast Media Scope and Market Size
MRI Contrast Media market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global MRI Contrast Media market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the MRI Contrast Media market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Injection Type
Oral Type
Segment by Application
Hospitals
Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
GE
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma